Search Results - richard+o%27brien

1 Results

Sort By:

MRM Assay Measurement of Amyloid Precursor Protein in Healthy and Alzheimers Disease Cerebrospinal Fluids

C12148: Method for Measuring Amyloid Precursor Proteins for Alzheimer’s DiseaseNovelty: This invention develops a method to measure the concentrations of various forms of Amyloid Precursor Proteins (APP) in cerebrospinal fluid (CSF).Value Proposition: Alzheimer's disease (AD) is the most common form of dementia. There is no cure for the disease....

Published: 3/13/2025 | Inventor(s): Jennifer Van Eyk, Xiaoqian Liu, Richard O'brien

Keywords(s): Alzheimer's Disease, Assay, Biomarker, Clinical Diagnostics, CNS and Neurological Disorders, Disease Indication, In Vitro Diagnostics, Mechanism-of-action Biomarker, Neurodegeneration, Therapeutic Matter, Therapeutics

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Geriatrics, Clinical and Disease Specializations > Neurology > Alzheimer's Disease, Clinical and Disease Specializations > Neurology > Neurodegeneration, Clinical and Disease Specializations > Rare Diseases, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Research Tools > Assays, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Neurology, Technology Classifications > Research Tools, Technology Classifications > Therapeutic Modalities